{
    "ASSETS": {
        "Current Assets": {
            "Cash and cash equivalents": [
                13979,
                14546
            ],
            "Marketable debt securities": [
                2987,
                1285
            ],
            "Receivables": [
                9369,
                8501
            ],
            "Inventories": [
                2095,
                2074
            ],
            "Other current assets": [
                4832,
                3786
            ],
            "Total Current Assets": [
                33262,
                30192
            ]
        },
        "Property, plant and equipment": [
            6049,
            5886
        ],
        "Goodwill": [
            20502,
            20547
        ],
        "Other intangible assets": [
            42527,
            53243
        ],
        "Deferred income taxes": [
            1439,
            1161
        ],
        "Marketable debt securities": [
            0,
            433
        ],
        "Other non-current assets": [
            5535,
            7019
        ],
        "Total Assets": [
            109314,
            118481
        ]
    },
    "LIABILITIES": {
        "Current Liabilities": {
            "Short-term debt obligations": [
                4948,
                2340
            ],
            "Accounts payable": [
                2949,
                2713
            ],
            "Other current liabilities": [
                13971,
                14027
            ],
            "Total Current Liabilities": [
                21868,
                19080
            ]
        },
        "Deferred income taxes": [
            4501,
            5407
        ],
        "Long-term debt": [
            39605,
            48336
        ],
        "Other non-current liabilities": [
            7334,
            7776
        ],
        "Total Liabilities": [
            73308,
            80599
        ],
        "Commitments and contingencies": null
    },
    "EQUITY": {
        "Bristol-Myers Squibb Company Shareholders Equity": {
            "Preferred stock, $2 convertible series, par value $ 1 per share: Authorized 10 million shares; issued and outstanding 3,484 in 2021 and 3,484 in 2020, liquidation value of $ 50 per share": [
                0,
                0
            ],
            "Common stock, par value of $ 0.10 per share: Authorized 4.5 billion shares; 2.9 billion issued in 2021 and 2020": [
                292,
                292
            ],
            "Capital in excess of par value of stock": [
                44361,
                44325
            ],
            "Accumulated other comprehensive loss": [
                -1268,
                -1839
            ],
            "Retained earnings": [
                23820,
                21281
            ],
            "Less cost of treasury stock 747 million common shares in 2021 and 679 million common shares in 2020": [
                -31259,
                -26237
            ],
            "Total Bristol-Myers Squibb Company Shareholders Equity": [
                35946,
                37822
            ]
        },
        "Noncontrolling interest": [
            60,
            60
        ],
        "Total Equity": [
            36006,
            37882
        ]
    },
    "Total Liabilities and Equity": [
        109314,
        118481
    ]
}